Patent · US Active

Crystalline forms of dimethoxy docetaxel and methods for preparing the same

US8846959B2 · kind B2 · utility

2Cited by

3References

1Claims

0Family size

Assignee

AVENTIS PHARMA S.A. · FR

Inventors

Pascal Billot · Paris, FR
Hagit Elmaleh · Paris, FR
Alexandre Giuliani · Villecresnes, FR

Key dates

Filing date	Feb 15, 2013
Grant date	Sep 30, 2014
Priority date	—
Expiry date	Feb 15, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2α-benzoyloxy-5β,20-epoxy-1-hydroxy-7β,10β-dimethoxy-9-oxo-tax-11-ene-13α-yle, and to the preparation thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.